People: Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

7 Aug 2020
Change (% chg)

$-3.71 (-4.10%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lidgard, Graham 

Dr. Graham Peter Lidgard Ph.D. serves as Senior Vice President, Chief Scientific Officer of the Company. He joined us from Nanogen Inc., a medical diagnostics products company, where he was senior vice president of research and development from 2003 to 2009. Prior to joining Nanogen, Dr. Lidgard led the research and development organization at Gen-Probe Inc., a molecular diagnostics company, which developed that company's Procleix blood screening products and Aptima sexually transmitted disease products, as well as the system development group at Gen-Probe that developed its fully automated Tigris system. Prior to joining Gen-Probe in 1995, Dr. Lidgard was co-founder and vice president of product development of Matritech Inc., a developer of diagnostic products for the early detection of bladder cancer. Before he co-founded Matritech, Dr. Lidgard held senior positions at Ciba Corning Diagnostics Corp.'s worldwide diagnostics group. While at Ciba Corning, he was involved in the development of more than 70 510(k)-cleared products. He led the program for the development of the magnetic particle chemiluminescent technology that became the ACS:180 and Centaur systems. Dr. Lidgard earned a bachelor's degree and a doctorate in biological chemistry from the University of Manchester in England.

Basic Compensation

Total Annual Compensation, USD 728,432
Restricted Stock Award, USD 891,837
Long-Term Incentive Plans, USD --
All Other, USD 464,709
Fiscal Year Total, USD 2,084,980

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Conroy


Jeffrey Elliott


D. Scott Coward


Graham Lidgard


Ana Hooker


Scott Johnson

As Of  31 Dec 2019